You are here

Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Herston, Queensland, Australia
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Prostatic Hyperplasia
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
40 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

1. Male subjects aged 40 years and above, with documented LUTS with an International
Prostate Symptom Score (IPSS) ≥13

2. Clinical diagnosis of BPH.

3. Qmax 5 to 15ml/sec with a voided volume of ≥150ml at visit 1 (screening).

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

1. Urinary tract infection

2. Primary neurological conditions affecting bladder function

NCT00457457
Pfizer
Completed
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now